First-time insights into the biosynthetic mechanism of fostriecin.
Research led by Prof. Dr. Frank Hahn at the University of Bayreuth.
New findings may enhance the yield and purity of the compound.
Briefing: Why a potential anti-cancer agent stalled in trials: New enzyme insights may boost yield and purity
Strategic angle: Researchers at the University of Bayreuth have deciphered key steps in the biosynthetic mechanism of fostriecin, a potential anti-cancer agent.